Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $2.91M
• Dividend Yield: N/A
• Average Volume (3M): 68.23K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.56
• Revenue Growth: -0.50%
• EPS Growth: 94.60%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 58
• Industry: Personal Products & Services
• EPS (TTM): -254.47
• Shares Outstanding: 2,119,551
• 10 Day Avg. Volume: 38,507
• 30 Day Avg. Volume: 68,235
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.20
• Price to Cash Flow (P/CF): -0.10
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Inspire Veterinary Partners, Inc. presents a challenging financial situation with persistent losses and negative cash flows. Although there is revenue growth, profitability and high leverage remain concerns. Technical indicators show bearish trends, and the valuation is unattractive due to negative earnings. The recent securities purchase agreement is a positive development, offering some strategic expansion potential, but the overall outlook remains cautious.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. Class A (IVP) is a company that operates in the veterinary services sector, focusing on providing comprehensive healthcare services for animals. The company is dedicated to enhancing the well-being of pets and livestock through its network of veterinary clinics, offering services such as medical consultations, surgical procedures, diagnostics, and preventive care.

How the Company Makes Money

Inspire Veterinary Partners, Inc. generates revenue through its network of veterinary clinics by offering a range of services to pet owners and livestock farmers. The company's primary revenue streams include fees for medical consultations, diagnostic tests, surgical procedures, and sales of veterinary products such as medications and pet food. Additionally, IVP may engage in partnerships with suppliers of veterinary products and pharmaceuticals, which can provide additional revenue through product sales and distribution agreements. Revenue is also supported by wellness plans and membership programs that encourage regular visits and preventive care, fostering customer loyalty and recurring income.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. Class A is navigating a difficult financial landscape characterized by revenue growth but persistent profitability challenges and high leverage. The income statement indicates consistent losses, while the balance sheet reflects a heavy reliance on debt with limited equity, posing risks to financial stability. Cash flow constraints further exacerbate the situation, highlighting a need for improved cash management and operational efficiency to sustain future growth and stability.

Income Statement

The income statement reveals a challenging financial position for Inspire Veterinary Partners, Inc. Class A. The company has experienced revenue growth over the years, with the most recent TTM (Trailing-Twelve-Months) revenue at $17.05 million, up from $16.68 million the previous year. However, the firm is struggling with negative profitability, as evidenced by a negative net profit margin and EBIT margin. The company has consistently reported net losses, with the latest net income at -$14.44 million, indicating significant profitability challenges.

Balance Sheet

The balance sheet shows a highly leveraged position, with a debt-to-equity ratio that indicates significant reliance on debt financing. As of the latest period, total debt stands at $16.99 million against stockholders' equity of $3.03 million. Although stockholders' equity has improved from a negative position in previous years, the company's equity ratio remains low, reflecting potential financial vulnerability. The increase in stockholders' equity is a positive sign, but the high debt levels pose ongoing risks.

Cash Flow

Cash flow analysis shows that Inspire Veterinary Partners, Inc. Class A is facing considerable cash flow challenges. The company reported negative operating cash flow of -$10.08 million and free cash flow of -$10.30 million in the latest TTM period. Although there is some capital raised through financing activities, it has not been sufficient to cover operational needs, resulting in negative cash flow to net income ratios. These figures suggest ongoing liquidity issues that may impact future operations.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
17.05M	16.68M	9.83M	2.55M	0.00
	Gross Profit
2.20M	3.55M	2.55M	829.29K	0.00
	EBIT
-9.18M	-7.19M	-3.52M	-1.05M	-5.52K
	EBITDA
-9.17M	-10.84M	-2.91M	-977.46K	0.00
	Net Income Common Stockholders
-14.44M	-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
21.97K	178.96K	444.25K	2.06M	21.97K
	Total Assets
0.00	21.79M	20.19M	6.33M	21.97K
	Total Debt
0.00	18.42M	23.61M	6.69M	0.00
	Net Debt
21.97K	18.24M	23.17M	4.64M	-21.97K
	Total Liabilities
0.00	22.58M	25.32M	7.20M	0.00
	Stockholders Equity
21.97K	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow		Free Cash Flow
-10.31M	-4.20M	-2.84M	-2.32M	-5.52K
	Operating Cash Flow
-10.08M	-3.82M	-2.66M	-1.01M	-5.52K
	Investing Cash Flow
-1.71M	-1.87M	-14.67M	-4.02M	0.00
	Financing Cash Flow
10.72M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.28
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 1.28 is below the 20-day moving average (MA) of 1.57, below the 50-day MA of 1.83, and below the 200-day MA of 34.71, indicating a bearish trend. The MACD of -0.17 indicates Positive momentum. The RSI at 34.42 is Neutral, neither overbought nor oversold. The STOCH value of 15.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	$6.54B	11.34	3.27%	4.27%	2.37%	-20.86%
JWEL	46 Neutral	$3.71M	―	-32.36%	―	-16.85%	-9.20%
VMAR	44 Neutral	$7.71M	―	-80.86%	―	-55.43%	55.17%
JXG	41 Neutral	$3.49M	4.09	22.23%	―	-21.60%	―
CTNT	41 Neutral	$4.25M	―	-28.60%	―	―	―
VEEE	40 Underperform	$3.32M	―	-51.70%	―	-57.08%	-45.74%
IVP	36 Underperform	$2.91M	―	-3687.07%	―	-0.50%	94.60%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Partners Announces Securities Purchase Agreement

On March 25, 2025, Inspire Veterinary Partners announced a securities purchase agreement with an institutional investor to issue and sell shares of Class A Common Stock and warrants in a registered direct offering expected to close on March 26, 2025. This offering, priced at $1.83 per share, aims to raise approximately $2.0 million initially, with the potential for an additional $4.0 million upon full exercise of the warrants. The company has engaged D. Boral Capital LLC as the placement agent and is required to seek stockholder approval for the issuance of shares upon warrant exercise within 75 days. The move is part of Inspire’s strategy to expand its operations and acquire more veterinary hospitals, enhancing its market positioning in the pet healthcare industry.

Inspire Veterinary Partners Announces Reverse Stock Split

On January 22, 2025, Inspire Veterinary Partners, Inc. announced a 1-for-25 reverse stock split of its Class A common stock, effective January 27, 2025. This move is intended to help the company comply with Nasdaq’s $1.00 minimum bid price requirement to maintain its listing. The reverse stock split will not affect any stockholder’s percentage interest in the company’s equity, and all changes will be uniformly applied.